252 related articles for article (PubMed ID: 32300060)
1. Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT.
Cortese M; Munger KL; Martínez-Lapiscina EH; Barro C; Edan G; Freedman MS; Hartung HP; Montalbán X; Foley FW; Penner IK; Hemmer B; Fox EJ; Schippling S; Wicklein EM; Kappos L; Kuhle J; Ascherio A;
Neurology; 2020 May; 94(18):e1950-e1960. PubMed ID: 32300060
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D
Smolders J; Mimpen M; Oechtering J; Damoiseaux J; van den Ouweland J; Hupperts R; Kuhle J
Acta Neurol Scand; 2020 Jan; 141(1):77-80. PubMed ID: 31657006
[TBL] [Abstract][Full Text] [Related]
3. Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
Fitzgerald KC; Munger KL; Köchert K; Arnason BG; Comi G; Cook S; Goodin DS; Filippi M; Hartung HP; Jeffery DR; O'Connor P; Suarez G; Sandbrink R; Kappos L; Pohl C; Ascherio A
JAMA Neurol; 2015 Dec; 72(12):1458-65. PubMed ID: 26458124
[TBL] [Abstract][Full Text] [Related]
4. No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.
Munger KL; Fitzgerald KC; Freedman MS; Hartung HP; Miller DH; Montalbán X; Edan G; Barkhof F; Suarez G; Radue EW; Sandbrink R; Kappos L; Pohl C; Ascherio A
Neurology; 2015 Nov; 85(19):1694-701. PubMed ID: 26453645
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D as an early predictor of multiple sclerosis activity and progression.
Ascherio A; Munger KL; White R; Köchert K; Simon KC; Polman CH; Freedman MS; Hartung HP; Miller DH; Montalbán X; Edan G; Barkhof F; Pleimes D; Radü EW; Sandbrink R; Kappos L; Pohl C
JAMA Neurol; 2014 Mar; 71(3):306-14. PubMed ID: 24445558
[TBL] [Abstract][Full Text] [Related]
6. EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.
Nejati A; Shoja Z; Shahmahmoodi S; Tafakhori A; Mollaei-Kandelous Y; Rezaei F; Hamid KM; Mirshafiey A; Doosti R; Sahraian MA; Mahmoudi M; Shokri F; Emery V; Marashi SM
Med Microbiol Immunol; 2016 Apr; 205(2):143-54. PubMed ID: 26365612
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.
Wergeland S; Myhr KM; Løken-Amsrud KI; Beiske AG; Bjerve KS; Hovdal H; Midgard R; Kvistad SS; Holmøy T; Riise T; Torkildsen Ø
Eur J Neurol; 2016 Jun; 23(6):1064-70. PubMed ID: 26998820
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
Salzer J; Nyström M; Hallmans G; Stenlund H; Wadell G; Sundström P
Mult Scler; 2013 Oct; 19(12):1587-91. PubMed ID: 23549431
[TBL] [Abstract][Full Text] [Related]
9. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.
Munger KL; Levin LI; O'Reilly EJ; Falk KI; Ascherio A
Mult Scler; 2011 Oct; 17(10):1185-93. PubMed ID: 21685232
[TBL] [Abstract][Full Text] [Related]
10. Epstein-barr virus and multiple sclerosis risk in the finnish maternity cohort.
Munger KL; Hongell K; Cortese M; Åivo J; Soilu-Hänninen M; Surcel HM; Ascherio A
Ann Neurol; 2019 Sep; 86(3):436-442. PubMed ID: 31226219
[TBL] [Abstract][Full Text] [Related]
11. Teriflunomide's effect on humoral response to Epstein-Barr virus and development of cortical gray matter pathology in multiple sclerosis.
Zivadinov R; Ramanathan M; Hagemeier J; Bergsland N; Ramasamy DP; Durfee J; Kolb C; Weinstock-Guttman B
Mult Scler Relat Disord; 2019 Nov; 36():101388. PubMed ID: 31525628
[TBL] [Abstract][Full Text] [Related]
12. Exploring the effect of vitamin D
Rolf L; Muris AH; Mathias A; Du Pasquier R; Koneczny I; Disanto G; Kuhle J; Ramagopalan S; Damoiseaux J; Smolders J; Hupperts R
Mult Scler; 2018 Sep; 24(10):1280-1287. PubMed ID: 28731372
[TBL] [Abstract][Full Text] [Related]
13. Effect of high-dose vitamin D
Røsjø E; Lossius A; Abdelmagid N; Lindstrøm JC; Kampman MT; Jørgensen L; Sundström P; Olsson T; Steffensen LH; Torkildsen Ø; Holmøy T
Mult Scler; 2017 Mar; 23(3):395-402. PubMed ID: 27325604
[TBL] [Abstract][Full Text] [Related]
14. Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS.
Håkansson I; Johansson L; Dahle C; Vrethem M; Ernerudh J
Mult Scler Relat Disord; 2019 Nov; 36():101424. PubMed ID: 31586802
[TBL] [Abstract][Full Text] [Related]
15. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.
Gieß RM; Pfuhl C; Behrens JR; Rasche L; Freitag E; Khalighy N; Otto C; Wuerfel J; Brandt AU; Hofmann J; Eberspächer B; Bellmann-Strobl J; Paul F; Ruprecht K
PLoS One; 2017; 12(4):e0175279. PubMed ID: 28388676
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for multiple sclerosis and associations with anti-EBV antibody titers.
Mouhieddine TH; Darwish H; Fawaz L; Yamout B; Tamim H; Khoury SJ
Clin Immunol; 2015 May; 158(1):59-66. PubMed ID: 25805657
[TBL] [Abstract][Full Text] [Related]
18. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
Lucas RM; Ponsonby AL; Dear K; Valery P; Pender MP; Burrows JM; Burrows SR; Chapman C; Coulthard A; Dwyer DE; Dwyer T; Kilpatrick T; Lay ML; McMichael AJ; Taylor BV; van der Mei IA; Williams D
Neurology; 2011 Jul; 77(4):371-9. PubMed ID: 21753179
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.
Castellazzi M; Contini C; Tamborino C; Fasolo F; Roversi G; Seraceni S; Rizzo R; Baldi E; Tola MR; Bellini T; Granieri E; Fainardi E
J Neuroinflammation; 2014 Nov; 11():188. PubMed ID: 25391491
[TBL] [Abstract][Full Text] [Related]
20. Blood neurofilament light chain as a biomarker of MS disease activity and treatment response.
Kuhle J; Kropshofer H; Haering DA; Kundu U; Meinert R; Barro C; Dahlke F; Tomic D; Leppert D; Kappos L
Neurology; 2019 Mar; 92(10):e1007-e1015. PubMed ID: 30737333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
